Fmr LLC Cure Vac N.V. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Fmr LLC holds 1,600 shares of CVAC stock, worth $7,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,600

Holding current value

$7,408

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$2.77 - $4.68 $4,432 - $7,488	1,600 New	1,600 $4,000
Q2 2022 Aug 12, 2022	SELL	$13.18 - $19.41 $2,385 - $3,513	-181 Reduced 6.61%	2,557 $35,000
Q1 2022 May 13, 2022	BUY	$14.73 - $35.25 $40,330 - $96,514	2,738 New	2,738 $54,000

Others Institutions Holding CVAC

# of Institutions

Shares Held

10.7M

Call Options Held

75.1K

Put Options Held

86.7K

Black Rock Inc. New York, NY

2.25M
Shares

$10.4 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.82M
Shares

$8.41 Million
0.0% of portfolio
Bill & Melinda Gates Foundation Seattle, WA

1.57M
Shares

$7.26 Million
10.6% of portfolio
Ubs Group Ag

843K
Shares

$3.9 Million
0.0% of portfolio
Gsa Capital Partners LLP London, X0

308K
Shares

$1.43 Million
0.08% of portfolio

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $868M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account